Search research articles
Contact Us
Filters
Showing results (61-70 of 347) with videos related to
Page
of 35
Sort By:
Clinical and Translational Medicine
|
August 27, 2024
The co-location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non-small cell lung cancer
Guangyu Fan, Tongji Xie, Le Tang, et al.
NPJ Precision Oncology
|
March 24, 2024
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma
Guangyu Fan, Tongji Xie, Lin Li, et al.
BMC Immunology
|
April 18, 2018
Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer
Puyuan Xing, Hongyu Wang, Sheng Yang, et al.
Cancer Science
|
November 29, 2021
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes
Rongrong Luo, Cuiling Zheng, Wenya Song, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 23, 2019
A new method of ultra-performance liquid chromatography/tandem mass spectrometry for determination of chlorogenic acid in human plasma and urine
Xiaohong Han, Ning Li, Shuxia Liu, et al.
Bioanalysis
|
March 19, 2020
A validated ultra-performance LC-MS/MS method for quantifying a novel oral EGFR inhibitor FCN-411 in human plasma
Shuxia Liu, Yuanyuan Song, Di Wu, et al.
Iscience
|
September 28, 2023
An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma
Guangyu Fan, Tongji Xie, Qiaoyun Tan, et al.
Epigenomics
|
January 23, 2023
Analysis on methylation and expression of <i>PSMB8</i> and its correlation with immunity and immunotherapy in lung adenocarcinoma
Tongji Xie, Guangyu Fan, Liling Huang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 24, 2011
[Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer]
Yan Wang, Lin Wang, Yutao Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 29, 2013
Absolute bioavailability studies of a new oral topotecan formulation in Chinese patients using UHPLC-MS/MS
Ning Li, Xiaohong Han, Jianliang Yang, et al.
Page
of 35
Search research articles
Search
Showing results (61-70 of 347) with videos related to
Sort By:
Page
of 35
Clinical and Translational Medicine
|
August 27, 2024
The co-location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non-small cell lung cancer
Guangyu Fan, Tongji Xie, Le Tang, et al.
NPJ Precision Oncology
|
March 24, 2024
Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma
Guangyu Fan, Tongji Xie, Lin Li, et al.
BMC Immunology
|
April 18, 2018
Therapeutic cancer vaccine: phase I clinical tolerance study of Hu-rhEGF-rP64k/Mont in patients with newly diagnosed advanced non-small cell lung cancer
Puyuan Xing, Hongyu Wang, Sheng Yang, et al.
Cancer Science
|
November 29, 2021
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes
Rongrong Luo, Cuiling Zheng, Wenya Song, et al.
Rapid Communications in Mass Spectrometry : RCM
|
November 23, 2019
A new method of ultra-performance liquid chromatography/tandem mass spectrometry for determination of chlorogenic acid in human plasma and urine
Xiaohong Han, Ning Li, Shuxia Liu, et al.
Bioanalysis
|
March 19, 2020
A validated ultra-performance LC-MS/MS method for quantifying a novel oral EGFR inhibitor FCN-411 in human plasma
Shuxia Liu, Yuanyuan Song, Di Wu, et al.
Iscience
|
September 28, 2023
An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma
Guangyu Fan, Tongji Xie, Qiaoyun Tan, et al.
Epigenomics
|
January 23, 2023
Analysis on methylation and expression of <i>PSMB8</i> and its correlation with immunity and immunotherapy in lung adenocarcinoma
Tongji Xie, Guangyu Fan, Liling Huang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 24, 2011
[Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer]
Yan Wang, Lin Wang, Yutao Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 29, 2013
Absolute bioavailability studies of a new oral topotecan formulation in Chinese patients using UHPLC-MS/MS
Ning Li, Xiaohong Han, Jianliang Yang, et al.
Page
of 35